FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

The FDA is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, part of a bid to get faster and leaner in evaluating drugs, foods, medical devices and diagnostic ...

While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the use of AI in clinical trials, the technology is still leaps and bounds ...